Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CJC-1295 without DAC (Mod GRF 1-29): Retains the same 29-amino-acid GHRH backbone but lacks the albumin-binding moiety
For more information or a special quotation, do not hesitate to contact us
Back to Journals ImmunoTargets and Therapy Volume 15 Recent Advances in Vitiligo Treatment Authors Qiu Y , Su X, Chen J, Jiang S, Tang X, He Y , Liu F Received 29 October 2025 Accepted for publication 1 February 2026 Published 11 February 2026 Volume 2026:15 577653 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Sarah Wheeler Ye Qiu, Xiangxi Su, Jingru Chen, Shaojing Jiang, Xinrui Tang, Yurong He, Fang Liu Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China Correspondence: Fang Liu, Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China, Email [email protected] Purpose: This review systematically summarizes breakthrough advances in vitiligo treatment from 2020 to 2025 to provide the latest evidence-based insights for clinical practice
Europe follows closely, while Asia-Pacific is experiencing rapid growth supported by expanding healthcare infrastructure and rising demand for advanced therapeutics
Increased consumption of fruits and vegetables are vital to alkalize the body and help the liver metabolize normally
US$ 21.33
US$ 27.62
US$ 21.13
